covaxin
-
Coronavirus: India records 30,549 cases on Tuesday – about 24% lower than Monday’s count
Scroll Staff
-
Covaxin’s quality problems slowed down vaccine supply, says Covid-19 panel chief
Scroll Staff
-
Covaxin is effective against Delta plus variant of coronavirus, finds ICMR study
Scroll Staff
-
Brazil suspends Covaxin’s import authorisation
Scroll Staff
-
Bharat Biotech cancels Covaxin deal with Brazil intermediary amid corruption allegations
Scroll Staff
-
Top 10 Covid updates: Submitted documents to WHO for Covaxin emergency approval, says Bharat Biotech
Scroll Staff
-
Brazil Supreme Court opens investigation into Jair Bolsonaro’s role in Covaxin scandal
Scroll Staff
-
Top 10 coronavirus updates: Karnataka eases restrictions, lifts weekend curfew
Scroll Staff
-
Covid-19: Here are the European countries that have recognised Indian vaccines so far
Niharika Sharma, qz.com
-
Coronavirus: Bharat Biotech confirms 77.8% efficacy of Covaxin in third phase trial data
Scroll Staff
-
Bharat Biotech says it followed ‘step-by-step’ approach for contract, approval of Covaxin in Brazil
Scroll Staff
-
Coronavirus: Brazil to suspend Covaxin contract amid inquiry into deal
Scroll Staff
-
Coronavirus: India reports 48,698 cases in last 24 hours, active cases below 6 lakh after 86 days
Scroll Staff
-
Brazil president denies irregularities in Covaxin deal
Scroll Staff
-
Coronavirus: Tamil Nadu extends curbs till July 5, allows more relaxations in certain districts
Scroll Staff
-
Brazil launches investigation into contract to buy Bharat Biotech’s Covaxin
Scroll Staff
-
Coronavirus: Maharashtra’s infection tally crosses 60-lakh mark, toll rises to 1,19,859
Scroll Staff
-
Covaxin shows 77.8% efficacy in phase 3 trials, say reports
Scroll Staff
-
Bharat Biotech submits phase 3 trial data of Covaxin, expert panel to meet today to discuss results
Scroll Staff
-
Covaxin does not contain newborn calf serum, clarifies health ministry amid speculation
Scroll Staff